The global ENT devices market was surpassed at USD 23.15 billion in 2022 and is expected to hit around USD 40.30 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
|Market Size in 2022||USD 23.15 billion|
|Revenue Forecast by 2032||USD 40.30 billion|
|Growth rate from 2023 to 2032||CAGR of 5.7%|
|Forecast Period||2023 to 2032|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Companies Covered||Demant A/S; Sonova; GN Store Nord A/S; Ambu A/S; Pentax Medical; Karl Storz; Olympus Corporation; Richard Wolf GmbH; Cochlear Ltd.; Starkey Laboratories, Inc.; Rion Co., Ltd.; Stryker; Smith & Nephew|
Increasing penetration of minimally invasive ENT procedures, increasing prevalence of ENT-related disorders, and rising geriatric population are among the key trends stimulating market growth. Technological advancements also play an important role in the growth of the market.
Demand for advanced ENT devices and systems, such as robot-assisted endoscopes, in developing economies is low due to high cost as their use is concentrated in developed economies, such as the U.S. However, increasing healthcare spending by other governments and a rise in per capita income are anticipated to significantly improve market penetration. Sales are expected to increase at a rapid pace in developing economies due to the high incidence of ENT diseases, such as hearing loss and sinusitis, and an increase in efforts to provide better access to healthcare facilities in these regions.
Hearing loss/impairment has become one of the most common conditions in patients, especially in industrialized countries. According to the WHO, there are over 460 million people worldwide, i.e., around 5% of the world’s population, living with disabling hearing loss, which is expected to increase to over 900 million or 1 in every 10 people by 2050. Two of the main reasons for this are growing life expectancy and increasing noise pollution, which means more cases of age-related hearing loss. Infections such as measles, middle ear infection, or meningitis are also common causes of hearing loss in low-income countries. Moreover, chronic inflammation, noise exposure, vascular disorders, physiological aging of the ear, and genetic susceptibility may cause hearing impairment.
Rising technological advancements such as the adoption of AI and ML and innovations in auditory products are propelling industry growth. For instance, in October 2021, Audibel, a health-technology company, launched Arc-AI, an AI hearing aid. It is programmed to automatically adjust hearing volume and is available in various styles, such as behind-the-ear and completely in-canal styles. In January 2019, Lively launched an online audiology platform that provides hearing aids, tests, and 24/7 online support for all clients. All users of the platform can communicate with an audiologist via video conference and receive hearing aid without the need to visit an office or retail store.
ENT products for minimally invasive procedures are dominated by companies such as Karl Storz, which offers HD video rhino-laryngoscope that can be used for visualization of the nose, pharynx, and larynx in HD image quality. Ambu, Inc. also offers single-use rhino-laryngoscope, which provides ENT specialists an alternative to reusable scopes. In March 2019, the company received CE Mark for Ambu aScope 4 RhinoLaryngo Slim.
ENT Devices Market Segmentations: